POSA104 The Cost of Metastatic Colorectal Cancer Patients with BRAFV600E Mutations in Greece

I Souglakos,I Athanasiadis,I Boukovinas,M Karamouzis,A Koutras,P Papakotoulas,D Latsou,M Hatzikou,E Stamuli

Value in Health（2022）

引用 0|浏览1

暂无评分

摘要

Tumor harboring BRAFV600E mutation are among the most aggressive forms of metastatic colorectal cancer (mCRC), with an estimated incidence of 8-12% of mCRC cases in Europe. The aim of this study is to explore the treatment strategy and economic burden of mCRC patients with BRAFV600E mutation in Greece.

查看译文

关键词

brafv600e mutations,metastatic colorectal cancer patients,metastatic colorectal cancer,colorectal cancer,cost

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要